BioCardia, Inc. 8-K

What Happened

• BioCardia, Inc. (BCDA) filed a Form 8-K on June 18, 2026 (Item 7.01) to furnish a press release that includes a letter to shareholders. The letter provides an update on the company’s business strategy, top priorities, and business development opportunities. The press release is attached as Exhibit 99.1 to the filing.

Key Details

• Filing date: June 18, 2026 (Form 8-K, Item 7.01 — Regulation FD Disclosure).
• Document provided: Press release containing the shareholder letter (Exhibit 99.1).
• Subject matter disclosed: company business strategy, top priorities, and business development opportunities.
• No earnings, executive changes, or financial statements were reported in this Form 8-K.

Why It Matters

• The disclosure gives investors management’s current view of strategic direction and where the company intends to focus resources and business-development efforts.
• Because it was furnished under Regulation FD, the information was broadly distributed to all investors at the same time, reducing the chance of selective disclosure.
• The filing itself does not provide new financial results or personnel changes; investors should review the attached press release for any operational details or follow-up announcements that might affect near-term expectations.